172 related articles for article (PubMed ID: 30821899)
1. Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue.
Ning M; Duarte JD; Stevison F; Isoherranen N; Rubin LH; Jeong H
Clin Transl Sci; 2019 Jul; 12(4):416-423. PubMed ID: 30821899
[TBL] [Abstract][Full Text] [Related]
2. Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate.
McConnachie L; Bodor M; Kowdley K; Levy A; Tung B; Thummel K; Phillips B; Bajpai M; Chi V; Esmay JD; Shen DD; Ho RJ
Clin Pharmacol Ther; 2004 Apr; 75(4):282-97. PubMed ID: 15060507
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 Protein Level Is the Major Contributor to Interindividual Variability in CYP2D6-Mediated Drug Metabolism in Healthy Human Liver Tissue.
Ning M; Duarte JD; Rubin LH; Jeong H
Clin Pharmacol Ther; 2018 Nov; 104(5):974-982. PubMed ID: 29349771
[TBL] [Abstract][Full Text] [Related]
4. Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.
Carcillo JA; Adedoyin A; Burckart GJ; Frye RF; Venkataramanan R; Knoll C; Thummel K; Roskos L; Wilson JW; Sereika S; Romkes M; Bebia Z; Branch RA
Clin Pharmacol Ther; 2003 May; 73(5):456-67. PubMed ID: 12732845
[TBL] [Abstract][Full Text] [Related]
5. Effects of Fenofibrate on the Expression of Small Heterodimer Partner (SHP) and Cytochrome P450 (CYP) 2D6.
Kent R; Jeong H
Drug Metab Lett; 2017 Nov; 11(1):68-72. PubMed ID: 28403802
[TBL] [Abstract][Full Text] [Related]
6. Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Kent R; Won KJ; Jeong H
Drug Metab Dispos; 2017 Apr; 45(4):346-352. PubMed ID: 28153841
[TBL] [Abstract][Full Text] [Related]
7. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.
He ZX; Chen XW; Zhou ZW; Zhou SF
Drug Metab Rev; 2015; 47(4):470-519. PubMed ID: 26574146
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.
Zanger UM; Fischer J; Raimundo S; Stüven T; Evert BO; Schwab M; Eichelbaum M
Pharmacogenetics; 2001 Oct; 11(7):573-85. PubMed ID: 11668217
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.
Zeng L; Chen Y; Wang Y; Yu LR; Knox B; Chen J; Shi T; Chen S; Ren Z; Guo L; Wu Y; Liu D; Huang K; Tong W; Yu D; Ning B
Biochem Pharmacol; 2017 Sep; 140():139-149. PubMed ID: 28552654
[TBL] [Abstract][Full Text] [Related]
10. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
Neafsey P; Ginsberg G; Hattis D; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
[TBL] [Abstract][Full Text] [Related]
12. Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol and dextromethorphan.
Uehara S; Uno Y; Hagihira Y; Murayama N; Shimizu M; Inoue T; Sasaki E; Yamazaki H
Xenobiotica; 2015; 45(9):766-72. PubMed ID: 25801057
[TBL] [Abstract][Full Text] [Related]
13. Inter-individual variation of several cytochrome P450 2D6 splice variants in human liver.
Denson J; Wu Y; Yang W; Zhang J
Biochem Biophys Res Commun; 2005 May; 330(2):498-504. PubMed ID: 15796910
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
Lee SS; Cha EY; Jung HJ; Shon JH; Kim EY; Yeo CW; Shin JG
Hepatology; 2008 Aug; 48(2):635-45. PubMed ID: 18666237
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Zhang W; McLachlan A; Urrutia R; Jeong H
Mol Pharmacol; 2014 Dec; 86(6):727-35. PubMed ID: 25217496
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of human cytochrome P450 2D6*10 in HepG2 cells.
Zhuge J; Yu YN; Wu XD
World J Gastroenterol; 2004 Jan; 10(2):234-7. PubMed ID: 14716830
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2D6 polymorphism and character traits.
Suzuki E; Kitao Y; Ono Y; Iijima Y; Inada T
Psychiatr Genet; 2003 Jun; 13(2):111-3. PubMed ID: 12782969
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Shen HW; Arnold SL; Yu AM; Gonzalez FJ; Isoherranen N; Jeong H
J Biol Chem; 2014 Feb; 289(6):3105-13. PubMed ID: 24318876
[TBL] [Abstract][Full Text] [Related]
19. Novel cytochrome P450-2D6 promoter sequence variations in hepatitis C positive and negative subjects.
Ho MT; Kelly EJ; Bodor M; Bui T; Kowdley KV; Ho RJ
Ann Hepatol; 2011; 10(3):327-32. PubMed ID: 21677335
[TBL] [Abstract][Full Text] [Related]
20. Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes.
Storelli F; Desmeules J; Daali Y
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):170-180. PubMed ID: 30192434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]